Trial intelligence / Profile preview

N-Acetylcysteine for Hearing Protection in Stapes Surgery

NCT00525551Phase 4Completed

Sponsor
Karolinska University Hospital
Start
Sep 2007
Primary completion
Apr 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of acetylcysteine in sensorineural hearing loss (SNHL), sponsored by Karolinska University Hospital. Started Sep 2007; status: completed.

02

Drugs

acetylcysteine
03

Conditions

sensorineural hearing loss (SNHL)

Beyond the preview

Go deeper on NCT00525551.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00525551.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call